28.3 C
New York
Friday, July 11, 2025

Tag: milestones

Rakovina Therapeutics Congratulates Partner – Variational AI for Winning LifeSciencesBC’s 2025 Emerging Biotech Company of the Year Award

Award Recognition underscores the importance of AI-driven drug discovery
Award Recognition underscores the importance of AI-driven drug discovery

MN8 Energy Successfully Closes $575 Million Senior Secured Notes Offering with Natixis Corporate & Investment Banking

Transaction Strengthens Capital Structure and Supports Continued Growth in Renewable Energy Portfolio NEW YORK, July 11, 2025 /PRNewswire/ -- MN8 Energy LLC ("MN8 Energy" or...

Aker Solutions ASA: Second-quarter and half-year results 2025

OSLO, Norway, July 11, 2025 /PRNewswire/ -- Aker Solutions delivered solid financial performance in the second quarter and in the first half of 2025. Several...

Aker Solutions ASA: Second-quarter and half-year results 2025

OSLO, Norway, July 11, 2025 /PRNewswire/ -- Aker Solutions delivered solid financial performance in the second quarter and in the first half of 2025. Several...

Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its previously announced upsized underwritten public offering of 25,555,556 shares of its common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock in the offering. The public offering price was $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were sold by Cogent.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMilestones